Hyderabad/UNI: In a step closer to developing COVID-19 vaccine, the clinical trials began at the Nizam's Institute of Medical Sciences (NIMS) here on Monday.
The first dose of the first indigenous vaccine--COVAXIN- being developed by the Hyderabad-based Bharat Biotech in association with the Indian Council of Medical Research (ICMR) was administered to two health volunteers.
The vaccine is likely to be tested on 30 healthy volunteers drawn from various parts of Telangana.
The volunteers will remain in the ICU care after the vaccine administration for some days before being discharged.
Their health condition and interaction with the vaccine will be monitored remotely and through physical checkups, according to the NIMS doctors.
Support Our Journalism
We cannot do without you.. your contribution supports unbiased journalism
IBNS is not driven by any ism- not wokeism, not racism, not skewed secularism, not hyper right-wing or left liberal ideals, nor by any hardline religious beliefs or hyper nationalism. We want to serve you good old objective news, as they are. We do not judge or preach. We let people decide for themselves. We only try to present factual and well-sourced news.
Support objective journalism for a small contribution.
